A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA.


Journal

BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563

Informations de publication

Date de publication:
19 Nov 2019
Historique:
received: 20 03 2019
accepted: 18 10 2019
entrez: 21 11 2019
pubmed: 21 11 2019
medline: 30 4 2020
Statut: epublish

Résumé

Eosinophilic lung diseases represent a heterogeneous group of disorders with prominent infiltrate of eosinophils in lung interstitium and alveolar spaces. Peripheral blood eosinophilia is often present. Infections, drugs, allergens, toxic agents have to be evaluated as possible causes of eosinophilic lung infiltrates. The category of myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 and PCM1-JAK2 represents an uncommon cause of eosinophilic lung infiltrate. We report the case of a 70-year old man complaining of dry cough and dyspnea. Ground glass-opacities were seen on imaging studies and peripheral blood eosinophilia was present. A thorough step-wise patient's evaluation led to identify the clonal nature of eosinophilia and the diagnosis of myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA was made. Correlation with clinical history, laboratory tests and imaging studies is essential to achieve the correct diagnosis when facing with eosinophilic lung infiltrates. A prolonged eosinophilia can cause life-threatening organ damage. Identification of PDGFRA rearrangement, as in the present case, is particularly critical given the sensitivity and excellent response to imatinib, which has completely changed the natural history of this neoplasm.

Sections du résumé

BACKGROUND BACKGROUND
Eosinophilic lung diseases represent a heterogeneous group of disorders with prominent infiltrate of eosinophils in lung interstitium and alveolar spaces. Peripheral blood eosinophilia is often present. Infections, drugs, allergens, toxic agents have to be evaluated as possible causes of eosinophilic lung infiltrates. The category of myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 and PCM1-JAK2 represents an uncommon cause of eosinophilic lung infiltrate.
CASE PRESENTATION METHODS
We report the case of a 70-year old man complaining of dry cough and dyspnea. Ground glass-opacities were seen on imaging studies and peripheral blood eosinophilia was present. A thorough step-wise patient's evaluation led to identify the clonal nature of eosinophilia and the diagnosis of myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA was made.
CONCLUSIONS CONCLUSIONS
Correlation with clinical history, laboratory tests and imaging studies is essential to achieve the correct diagnosis when facing with eosinophilic lung infiltrates. A prolonged eosinophilia can cause life-threatening organ damage. Identification of PDGFRA rearrangement, as in the present case, is particularly critical given the sensitivity and excellent response to imatinib, which has completely changed the natural history of this neoplasm.

Identifiants

pubmed: 31744552
doi: 10.1186/s12890-019-0967-7
pii: 10.1186/s12890-019-0967-7
pmc: PMC6862820
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

216

Références

Arch Pathol Lab Med. 2016 Oct;140(10):1060-7
pubmed: 27684977
Int J Lab Hematol. 2019 Apr;41(2):153-161
pubmed: 30499630
Semin Respir Crit Care Med. 2012 Oct;33(5):555-71
pubmed: 23001808
Clin Chest Med. 2016 Sep;37(3):535-56
pubmed: 27514599
J Biol Chem. 2014 Jun 20;289(25):17406-15
pubmed: 24802755
Blood. 2017 Feb 9;129(6):704-714
pubmed: 28028030
Am J Hematol. 2017 Nov;92(11):1243-1259
pubmed: 29044676

Auteurs

Magda Zanelli (M)

Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Maxwell Smith (M)

Department of Pathology and Laboratory Medicine, Mayo Clinic, Scottsdale, AZ, USA.

Maurizio Zizzo (M)

Surgical Oncology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy. zizzomaurizio@gmail.com.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy. zizzomaurizio@gmail.com.

Angelo Carloni (A)

Radiology Unit, Ospedale di Terni, University of Perugia, Perugia, Italy.

Riccardo Valli (R)

Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Loredana De Marco (L)

Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Moira Foroni (M)

Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Andrea Palicelli (A)

Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Giovanni Martino (G)

Hematology Unit, CREO, University of Perugia, Perugia, Italy.

Stefano Ascani (S)

Pathology Unit, Ospedale di Terni, University of Perugia, Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH